Streetbeat News

Revenues

DIS

Disney+ reported a significant increase in its core subscriber base, with over 6 million new subscribers in the second quarter. Additionally, the Average Revenue Per User (ARPU) for Disney+ Core increased by 44 cents sequentially.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:36 am

ARMK

Aramark forecasts a 9% revenue growth and an adjusted EPS growth of 30% to 35% for fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:33 am

SEAT

Vivid Seats reported Q1 sales of $190.852M, surpassing the $181.668M estimate, marking an 18.50% increase YoY. However, net income fell by 65% to $10.7M.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:32 am

NPO

Enpro has reaffirmed its forecast for FY24, expecting revenue growth in the low to mid-single digit range.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:32 am

COTY

Coty Inc's shares rose after reporting Q3 FY24 sales growth of 8% to $1.386 billion, surpassing analyst estimates. Growth was seen across all regions and product categories, with e-commerce revenue up nearly 20%. However, adjusted EPS missed estimates by $0.01. The company expects FY24 LFL revenue growth at the high end of its 9%-11% guidance and adjusted EPS at the higher end of $0.44-$0.47. Despite positive sales growth, operating cash flow was negative.

Portfolio Pulse from Shivani Kumaresan

May 07, 2024 | 10:32 am

ARMK

Aramark (NYSE:ARMK) reported Q2 adjusted earnings of $0.29 per share, surpassing the $0.27 estimate, marking a 3.57% year-over-year increase. However, their $4.20B sales fell short of the $4.24B estimate, reflecting an 8.74% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:31 am

OSCR

Oscar Health announced a Q1 medical loss ratio of 74.2%, and its total membership increased to 1.44 million from 1.02 million a year ago.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:12 am

GEO

GEO Group updated its 2024 financial guidance, projecting annual revenues of approximately $2.4B, slightly below the estimated $2.45B. The company now expects Net Income to range between $55M and $75M, down from the previous forecast of $110M to $125M, attributing the decrease to an $86M loss on debt extinguishment due to refinancing in Q2 2024. The adjusted EBITDA forecast is set between $485M and $515M.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:09 am

KNF

Knife River has reaffirmed its fiscal year 2024 revenue guidance to be in the range of $2.75 billion to $2.95 billion, aligning with the market estimate of $2.88 billion.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:08 am

ESPR

Esperion Therapeutics projects its FY24 revenues to be between $225M-$245M, which includes $20M in non-cash expenses related to stock compensation.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:04 am